Evaluation of various insulin sensitivity indices in lean idiopathic hirsutism patients

Endocrine Journal

Volumn 59, Issue 4, 2012, Pages 291-296

  Ucak, Sema ^a   Basat, Okcan ^a   Satir, Emine ^a   Altuntas, Yuksel ^a  

^a SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Idiopathic hirsutism; Insulin resistance; Insulin sensitivity indices; Lean patients

Indexed keywords

FOLLITROPIN; GLUCOSE; INSULIN; LUTEINIZING HORMONE; PRASTERONE SULFATE; TESTOSTERONE;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HIRSUTISM; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL ANALYSIS;

ADOLESCENT; ADULT; CROSS-SECTIONAL STUDIES; FASTING; FEMALE; HIRSUTISM; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; MODELS, BIOLOGICAL;

EID: 84860648766     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ11-0101     Document Type: Article

References (33)

1. Bulun SE, Adashi YA (2008) The Physiology and pathology of the female reproductive axis. In: Kronenberg HM, Melmed S, Polonsky KS, Larsen PR (eds) Williams textbook of endocrinology. Saunders Elsevier, Philelphia:541-614.
2. Hatch R, Rosenfield RL, Kim MH, Tredway D (1981) Hirsutism: implications, etiology and management. Am J Obstet Gynecol 140:815-830.
3. McAuley KA, Williams SM, Mann JI et al. (2001) Diagnosing insulin resistance in the general population. Diabetes Care 24: 460-464.
4. Hoffman DI, Klove K, Lobo RA (1984) The prevalence and significance of elevated dehydroepiandrosterone sulfate levels in anovulatory women. Fertil Steril 42:76.
5. Raynaud E, Perez-Martin A, Brun J-F, Benhaddad AA, Mercier J (1999) Revised concepts for the estimation of insulin sensitivity from a single sample. Diabetes Care 22:1003.
6. Belfiore F, Iannello S, Volpicelli G (1998) Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Mol Genet Metab 63: 134-141.
7. Duncan MH, Singh BM, Wise PH, Carter G, Alaghband-Zadeh J (1995) A simple measure of insulin resistance. Lancet 346:120-121.
8. Katz A, Nambi SS, Mather K, et al. (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85:2402-2410.
9. Ludvig B, Nolan JJ, Baloga J, et al. (1995) Effect of obesity on insulin resistance in normal subject and patients with NIDDM. Diabetes 44:1121-1125.
10. Marques-Vidal P, Mazoyer E, Bongard V, et al. (2002) Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers. Diabetes Care 25:1371-1377.
11. Jiang M, Aittomäki K, Nilsson C, et al. (1998) The frequency of an inactivating point mutation (566C-->T) of the human follicle-stimulating hormone receptor gene in four populations using allele-specific hybridization and time-resolved fluorometry. J Clin Endocrinol Metab 83:4338-4343.
12. Parks JS, Brown MR (1999) Transcription factors regulating pituitary development. Growth Horm IGF Res 9: 8-11.
13. Mandarino L, Baker B, Rizza R, et al. (1984) Infusion of insulin impairs human adipocyte glucose metabolism in vitro without decreasing adipocyte insulin receptor binding. Diabetologia 27:358-363.
14. Burghen GA, Givens JR, Kitabchi AK (1980) Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J Clin Endocrinol Metab 50:113-116.
15. Chang RJ, Nakamura RM, Judd HI, Kaplan SA (1983) Insulin resistance in non-obese patients with polycystic ovarian disease. J Clin Endocrinol Metab 57:356-359.
16. Jialal T, Naiker P, Reddi K, et al. (1987) Evidence for insulin resistance in nonobese patients with polycystic ovarian disease. J Clin Endocrinol Metab 64:1066-1069.
17. Dunaif A, Segal KR, Futterweit W, Dobriansky A (1989) Profound peripheral insulin resistance independent of obesity, in polycystic ovarian syndrome. Diabetes 38:1165-1174.
18. Toprak S, Yonem A, Cakir B, et al. (2001) Insulin resistance in nonobese patients with polycystic ovary syndrome. Horm Res 55: 65-70.
19. Ovalle F, Azziz R (2002) Insulin resistance, polycystic ovary syndrome, and type 2 diabetes mellitus. Fert Steril 77:1095-1105.
20. Unluhizarci K, Karababa Y, Bayram F, Kelestimur F (2004) The investigation of insulin resistance in patients with idiopathic hirsutism. JCEM 89:2741-2744.
21. Sarac F, Saygili F, Ozgen G, Tuzun M, Yilmaz C, Kabalak T (2007) Assessment of insulin resistance in idiopathic hirsutism. Gynecol Obstet Invest 63:126-131.
22. Abdel Fattah NS, Darwish YW (2009) Is there a role for insulin resistance in nonobese patients with idiopathic hirsutism? Br J Dermatol 160:1011-1015.
23. Altuntas Y, Bilir M, Ozturk B, Gundogdu S (2003) Comparison of various simple insulin sensitivity and beta-cell function indices in lean hyperandrogenemic and normoandrogenemic young hirsute women. Fertil Steril 80:133-142.
24. Itami S, Kurata S, Takayasu S (1995) Androgen induction of follicular epithelial cell growth is mediated via insulin-like growth factor-I from dermal papilla cells. Biochem Biophys Res Commun 212:988-994.
25. Philpott MP, Sanders DA, Kealey T (1994) Effects of insulin and insulin-like growth factors on cultured human hair follicles: IGF-I at physiologic concentrations is an important regulator of hair follicle growth in vitro. J Invest Dermatol 102:857-861.
26. Su HY, Hickford JG, Bickerstaffe R, Palmer BR (1999) Insulin-like growth factor 1 and hair growth. Dermatol Online J 5:1.
27. Weger N, Schlake T (2005) Igf-I signalling controls the hair growth cycle and the differentiation of hair shafts. J Invest Dermatol 125:873-882.
28. Kooijman R (2006) Regulation of apoptosis by insulinlike growth factor (IGF)-I. Cytokine Growth Factor Rev 17:305-23.
29. Butler ST, Marr AL, Pelton SH, Radcliff RP, Lucy MC, Butler WR (2003) Insulin restores GH responsiveness during lactation-induced negative energy balance in dairy cattle: effects on expression of IGF-I and GH receptor 1A. J Endocrinol 176:205-217.
30. Le Roith D, Roberts CTJr (2003) The insulin-like growth factor system and cancer. Cancer Let 195:127-37.
31. Gallagher EJ. et al. (2010) The increased risk of cancer in obesity and type 2 diabetes: potential mechanisms. In: Poretsky L (ed) Principles of Diabetes Mellitus. Springer, US: 2010:583
32. Le Roith D, Werner H, Beitner-Johnson D, Roberts CT Jr (1995): Molecular and cellular aspects of the insulinlike growth factor I receptor. Endocr Rev 16:143-163.
33. Yakar S, Pennisi P, Kim CH, et al. D (2005): Studies involving the GH-IGF axis: Lessons from IGF-I and IGF-I receptor gene targeting mouse models. J Endocrinol Invest 28:19-22.